87 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
renewable energy footprint; and
◦Incorporating new ESG metrics into the executive compensation program and advancing data privacy and cybersecurity efforts
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
renewable source by 2026 through VPPA*
Committed to Sound Corporate Governance 6 Board Accountability and Shareholder Rights Regular shareholder engagement
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
liabilities (excluding liabilities that are extendable or renewable at the option of the obligor to a date more than 12 months after the date as of which … deducting: (i) all current liabilities (excluding liabilities that are extendable or renewable at the option of the obligor to a date more than 12 months
424B2
BMY
Bristol-Myers Squibb Co.
13 Feb 24
Prospectus for primary offering
8:00am
deductible items) after deducting: (i) all current liabilities (excluding liabilities that are extendable or renewable at the option of the obligor to a date … reserves and other properly deductible items) after deducting: (i) all current liabilities (excluding liabilities that are extendable or renewable
424B5
BMY
Bristol-Myers Squibb Co.
1 Nov 23
Prospectus supplement for primary offering
4:16pm
liabilities that are extendable or renewable at the option of the obligor to a date more than 12 months after the date as of which the amount is being … and other properly deductible items) after deducting: (i) all current liabilities (excluding liabilities that are extendable or renewable at the option
424B3
1cho46
30 Oct 23
Prospectus supplement
8:05am
DEFA14A
aidguq83y62zow6ww
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.3
11t9mzogvcexu3
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
DEFA14A
7l3rft66 3j5w
20 Apr 22
Additional proxy soliciting materials
4:30pm
424B5
u7qarq
17 Feb 22
Prospectus supplement for primary offering
4:47pm
424B3
jqkdmm
15 Feb 22
Prospectus supplement
9:13am
8-K
EX-99.3
0dcqa
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am
S-3ASR
u44oy1gwg
13 Dec 21
Automatic shelf registration
4:31pm
8-K
EX-99.1
4aanppxlf
16 Nov 21
Regulation FD Disclosure
9:20am